Company / Operating Cash Flow per Share
TherapeuticsMD, Inc. Operating Cash Flow per Share History
FY2015-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Cash Flow per Share
-$2.00
FY2024
5-year range
-$6.41 / $0.99
FY2020-FY2024
Trend
-303.1%
vs FY2023
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Operating Cash Flow per Share changed -303% YoY in FY2024, a notable deviation from the 9-year average annual change of -159%.
Based on SEC 10-K filings.
-2.00 in FY2024.
Improved from $-6.41 to $-2.00 over the past 2 years.
Operating Cash Flow per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2024, operating cash flow per share decreased 303.1% year-over-year.
- Peak operating cash flow per share was recorded in FY2023.
- Lowest operating cash flow per share in the period was in FY2022.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score 0.77 (distress zone, below 1.8 threshold)
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating Cash Flow per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2024 | -$2.00 | -303.1% |
| FY2023 | $0.99 | +115.4% |
| FY2022 | -$6.41 | -1059.9% |
| FY2021 | -$0.55 | -40.4% |
| FY2020 | -$0.39 | -24.4% |
| FY2019 | -$0.32 | +0.9% |
| FY2018 | -$0.32 | +20.5% |
| FY2017 | -$0.40 | -57.1% |
| FY2016 | -$0.26 | -78.6% |
| FY2015 | -$0.14 | -63.0% |
As of FY2024 · SEC 10-K · Updated Jun 28, 2026